MEDICAL IP to attract investment in Series C... Partnership with Dong-A Socio Holdings

MEDICAL IP attracts 20 billion KRW Series C investment

▶ Expected to strengthen competitiveness in the medical market through partnership with Dong-A Socio Holdings, which participated in SI

Medicalip Series C

MEDICALIP has completed attracting 20 billion won of Series C investment.

In particular, Dong-A Socio Holdings, which has many affiliates in the medical field such as Dong-A ST and Dong-A Pharmaceutical, participated as a strategic investor in this investment MEDICAL IP expected to strengthen competitiveness in the medical field and expand the market in earnest.

Dong-A Socio Holdings plans to join with MEDICALIP to foster artificial intelligence healthcare business and create new business opportunities.

CEO Park Sang-joon said, “MEDICALIP is building a differentiated business model that can predict and even monitor diseases using medical AI.”

He continued, “Both FI and SI highly evaluated the company’s technological competitiveness, and we successfully attracted a total of KRW 20 billion in investment. By using this, we will strive to advance the technology, commercialize medical AI products, and enter the global healthcare market.”


Jun 18 / 2024

[MedTech] 'Augmented Reality' Enters the Operating Room, Providing '3D Color Visualization' from 2D Flat Medical Image

Jun 18 / 2024

MEDICAL IP participated in ‘HIMSS 2024 Europe,’ introducing their personalized liver cancer solutions.

Mar 7 / 2024

MEDICAL IP, selected as “Top 10 R&D in cross-government medical devices of 2024 KMDF” through Extended Reality Technology


Questions on our public relations?

Ask us now.